HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DUALITYBIO-B

170.300

-13.600-7.40%

Volume:1.38M

Turnover:240.08M

Market Cap:15.47B

PE:-3.66

High:182.200

Open:181.500

Low:170.000

Close:183.900

52wk High:563.500

52wk Low:158.500

Shares:90.83M

HK Float Shares:90.83M

Volume Ratio:1.53

T/O Rate:1.52%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-46.487

ROE:-65.93%

ROA:-24.28%

PB:9.13

PE(LYR):-3.66

PS:15.73

Loading ...

Overview Company News Filings

DUALITYBIO-B (09606) Spends HK$6.5144 Million on Share Buyback

LAV Asset Management Boosts Stake in DUALITYBIO-B with 105,000 Share Purchase

Duality Biotherapeutics Launches $40 Million Stock Buyback; Shares Rise 3%

MT Newswires Live

DualityBio-B Surges Nearly 5% in Morning Trading, Announces Up to $40 Million Share Buyback Plan

Movement Alert｜Duality Biotherapeutics Rises 5.66% in Regular Trading, Share Buyback Plan Triggers Rebound After Multi-Day Selloff

DUALITYBIO-B (09606) Announces Up to $40 Million Share Buyback, Founder Plans Additional $5 Million Purchase

Duality Biotherapeutics Inc - Announces Share Repurchase Plan of up to $40 Mln

THOMSON REUTERS

DUALITYBIO-B Exercises Option for U.S. Cost and Profit/Loss Sharing on DB-1311/BNT324

Duality Biotherapeutics Exercises U.S. Cost- and Profit-Sharing Option for ADC Candidate DB-1311/BNT324 in Collaboration with BioNTech

Bulletin Express

HK Movers | Biotech Stocks Jump. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%

Tiger Newspress

DualityBio-B Adds 0.19 Million New Shares in April; Public Float Remains Compliant

Bulletin Express

Duality Biotherapeutics shareholders approved RMB share issue plan at EGM

HK Movers | Biotech Stocks Jump. Wuxi Apptec Soars 14% as 1Q Net Profit Rises 26.7%; Junshi Bio up 8%; Asymchem up Nearly 7%; Pharmaron up 4%

Tiger Newspress

DUALITYBIO-B 2025年度：营收约18.52亿元小幅下滑，净亏损增至25.95亿元，股本由负转正

Bulletin Express

DualityBio publishes 2025 ESG report

HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%

Tiger Newspress

China International Capital Corporation: National Policy Optimizes Initial Pricing Mechanism for Innovative Drugs, Pharmaceutical Sector Set for High-Quality Development

Stock Track | DUALITYBIO-B Soars 5.02% Intraday on STAR Market Listing Plan Announcement

DualityBio-B Advances Global ADC Leadership with Dual Capital Platform Strategy

DualityBio Convenes 29 April 2026 EGM to Approve RMB Share Issue and Corporate Governance Amendments

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/09606/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"09606","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"DUALITYBIO-B","latestPrice":170.3,"timestamp":1789027724007,"preClose":183.9,"halted":0,"volume":1380500,"delay":0,"changeRate":-0.07395323545405108,"floatShares":90833600,"shares":90833600,"eps":-46.486649676534014,"marketStatus":"Not Yet Opened","change":-13.6,"latestTime":"09-10 16:08:44","open":181.5,"high":182.2,"low":170,"amount":240077328,"amplitude":0.06634,"askPrice":170.3,"askSize":5500,"bidPrice":170.2,"bidSize":900,"shortable":3,"etf":0,"ttmEps":-18.821415440501866,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":0,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":183.9,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":1.5312381457422164,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","floatShares":90833600,"roa":"-24.28%","roe":"-65.93%","lyrEps":-46.48665,"volumeRatio":1.5312381457422164,"shares":90833600,"dividePrice":0,"high":182.2,"amplitude":0.06634,"preClose":183.9,"low":170,"week52Low":158.5,"pbRate":"9.13","psRate":"15.73","week52High":563.5,"institutionHeld":0,"latestPrice":170.3,"committee":-0.71875,"eps":-46.486649676534014,"divideRate":0,"volume":1380500,"delay":0,"ttmEps":-18.821415440501866,"open":181.5,"prevYearClose":298.2,"prevWeekClose":180.7,"prevMonthClose":184.3,"prevQuarterClose":181.2,"fiveDayClose":183.5,"twentyDayClose":192,"sixtyDayClose":181.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09606\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null},{"date":"2026-03-23","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774229400000,"name":null,"time":"","dateTimestamp":1774195200000,"actualEps":null},{"date":"2025-08-26","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09606\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09606\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1786723200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09606\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09606","date":"2026-09-09","current":-9.048204,"percent":0.350725,"low":-29.984477,"twenty":-16.166712,"median":-9.338798,"eighty":-6.786974,"high":-4.703556,"avg":-11.552661,"sd":6.162367,"marketCap":16634272494},"quantilePoints":[{"date":"2025-04-17","current":-14.905978,"twenty":-15.065639,"median":-14.442293,"eighty":-11.334487,"marketCap":16635152800},{"date":"2025-04-25","current":-15.846935,"twenty":-16.770434,"median":-15.576033,"eighty":-14.349556,"marketCap":17719522633},{"date":"2025-05-02","current":-16.438538,"twenty":-16.715855,"median":-16.124153,"eighty":-14.985809,"marketCap":18420101638},{"date":"2025-05-09","current":-15.074661,"twenty":-16.551291,"median":-15.826729,"eighty":-15.074661,"marketCap":17010399982},{"date":"2025-05-16","current":-15.043786,"twenty":-16.438538,"median":-15.220044,"eighty":-14.405796,"marketCap":17114249721},{"date":"2025-05-23","current":-16.495727,"twenty":-16.438538,"median":-15.262587,"eighty":-14.582474,"marketCap":18822153243},{"date":"2025-05-30","current":-16.208434,"twenty":-16.401371,"median":-15.460562,"eighty":-14.726132,"marketCap":18575651704},{"date":"2025-06-06","current":-16.427701,"twenty":-16.438538,"median":-15.666395,"eighty":-14.905978,"marketCap":18874975001},{"date":"2025-06-13","current":-20.940103,"twenty":-16.693343,"median":-15.893657,"eighty":-15.005253,"marketCap":24069114577},{"date":"2025-06-20","current":-18.479443,"twenty":-18.428819,"median":-16.104695,"eighty":-15.043786,"marketCap":21199132371},{"date":"2025-06-27","current":-18.0452,"twenty":-18.863356,"median":-16.282988,"eighty":-15.074661,"marketCap":20758951051},{"date":"2025-07-04","current":-21.227749,"twenty":-18.942282,"median":-16.427701,"eighty":-15.074735,"marketCap":24421259633},{"date":"2025-07-11","current":-22.045806,"twenty":-19.683704,"median":-16.508309,"eighty":-15.190609,"marketCap":25336836779},{"date":"2025-07-18","current":-25.758166,"twenty":-20.839221,"median":-16.693343,"eighty":-15.21995,"marketCap":29580184704},{"date":"2025-07-25","current":-25.970367,"twenty":-21.539184,"median":-16.981252,"eighty":-15.260218,"marketCap":29932329760},{"date":"2025-08-01","current":-24.963588,"twenty":-22.267132,"median":-18.096065,"eighty":-15.298157,"marketCap":28594178547},{"date":"2025-08-08","current":-27.998627,"twenty":-24.402884,"median":-18.454131,"eighty":-15.429476,"marketCap":32150843612},{"date":"2025-08-15","current":-27.487815,"twenty":-25.397092,"median":-18.863356,"eighty":-15.513126,"marketCap":31516982512},{"date":"2025-08-22","current":-26.341915,"twenty":-25.761111,"median":-19.052333,"eighty":-15.750472,"marketCap":30108402288},{"date":"2025-08-29","current":-8.977182,"twenty":-25.761111,"median":-19.118727,"eighty":-15.513126,"marketCap":27784244918},{"date":"2025-09-05","current":-10.341403,"twenty":-25.547361,"median":-18.897362,"eighty":-15.21995,"marketCap":31974771084},{"date":"2025-09-12","current":-12.806892,"twenty":-25.484142,"median":-18.479443,"eighty":-15.036079,"marketCap":39669140558},{"date":"2025-09-19","current":-11.291493,"twenty":-25.397092,"median":-18.151913,"eighty":-14.569138,"marketCap":34950396808},{"date":"2025-09-26","current":-9.575685,"twenty":-25.265241,"median":-17.183112,"eighty":-14.242848,"marketCap":29562577451},{"date":"2025-10-03","current":-9.769092,"twenty":-25.225948,"median":-16.756996,"eighty":-13.467837,"marketCap":30231653057},{"date":"2025-10-10","current":-8.39875,"twenty":-25.201143,"median":-16.551291,"eighty":-12.508489,"marketCap":25953090627},{"date":"2025-10-17","current":-9.52866,"twenty":-25.090759,"median":-16.467132,"eighty":-11.127698,"marketCap":29421719428},{"date":"2025-10-24","current":-8.24833,"twenty":-24.683236,"median":-16.401371,"eighty":-10.383008,"marketCap":25477694801},{"date":"2025-10-31","current":-8.936138,"twenty":-24.228898,"median":-16.208434,"eighty":-10.01166,"marketCap":27643386896},{"date":"2025-11-07","current":-8.115895,"twenty":-24.0933,"median":-15.983588,"eighty":-9.661913,"marketCap":25090335240},{"date":"2025-11-14","current":-9.615008,"twenty":-24.036348,"median":-15.846935,"eighty":-9.533336,"marketCap":29809078990},{"date":"2025-11-21","current":-8.88084,"twenty":-23.659864,"median":-15.493415,"eighty":-9.411746,"marketCap":27520136126},{"date":"2025-11-28","current":-9.805814,"twenty":-23.032171,"median":-15.270261,"eighty":-9.358381,"marketCap":30496838785},{"date":"2025-12-05","current":-9.522579,"twenty":-22.810207,"median":-15.147164,"eighty":-9.358381,"marketCap":29666872704},{"date":"2025-12-12","current":-9.227769,"twenty":-22.078047,"median":-15.043786,"eighty":-9.232281,"marketCap":28801588916},{"date":"2025-12-19","current":-9.562517,"twenty":-22.024358,"median":-14.816055,"eighty":-9.195431,"marketCap":29916743432},{"date":"2025-12-24","current":-8.86445,"twenty":-21.960012,"median":-14.582474,"eighty":-9.185632,"marketCap":27819193982},{"date":"2026-01-02","current":-8.361415,"twenty":-21.780535,"median":-14.405796,"eighty":-9.071858,"marketCap":26343799029},{"date":"2026-01-09","current":-10.158481,"twenty":-21.573184,"median":-14.143758,"eighty":-9.138635,"marketCap":32085396254},{"date":"2026-01-16","current":-10.130227,"twenty":-21.338723,"median":-13.671075,"eighty":-9.159542,"marketCap":32100133626},{"date":"2026-01-23","current":-9.450777,"twenty":-21.128733,"median":-12.833558,"eighty":-9.159542,"marketCap":29918397524},{"date":"2026-01-30","current":-9.27281,"twenty":-20.989151,"median":-11.556174,"eighty":-9.159542,"marketCap":29489203537},{"date":"2026-02-06","current":-8.834279,"twenty":-20.864442,"median":-11.154997,"eighty":-9.026205,"marketCap":28165855410},{"date":"2026-02-13","current":-9.445101,"twenty":-20.730279,"median":-10.443288,"eighty":-9.076015,"marketCap":30286271904},{"date":"2026-02-20","current":-9.824687,"twenty":-20.674464,"median":-10.43817,"eighty":-9.09489,"marketCap":31458062186},{"date":"2026-02-27","current":-8.771359,"twenty":-20.006759,"median":-10.305855,"eighty":-9.047703,"marketCap":28393379910},{"date":"2026-03-06","current":-8.859488,"twenty":-19.896232,"median":-10.18539,"eighty":-8.969972,"marketCap":28447462538},{"date":"2026-03-13","current":-7.555838,"twenty":-19.630572,"median":-10.144354,"eighty":-8.935093,"marketCap":24373237865},{"date":"2026-03-20","current":-7.859442,"twenty":-19.432697,"median":-9.991099,"eighty":-8.867218,"marketCap":25256587462},{"date":"2026-03-27","current":-8.718949,"twenty":-19.118727,"median":-9.951719,"eighty":-8.854358,"marketCap":25617138318},{"date":"2026-04-02","current":-9.880216,"twenty":-19.012497,"median":-9.885599,"eighty":-8.850342,"marketCap":29168564250},{"date":"2026-04-10","current":-9.180446,"twenty":-18.964111,"median":-9.878849,"eighty":-8.85641,"marketCap":27311727342},{"date":"2026-04-17","current":-9.417233,"twenty":-18.904163,"median":-9.820225,"eighty":-8.842311,"marketCap":28027927148},{"date":"2026-04-24","current":-8.878352,"twenty":-18.860571,"median":-9.805814,"eighty":-8.846908,"marketCap":26425587896},{"date":"2026-04-30","current":-8.372511,"twenty":-18.781003,"median":-9.783435,"eighty":-8.82699,"marketCap":24926391864},{"date":"2026-05-08","current":-7.738947,"twenty":-18.469318,"median":-9.736996,"eighty":-8.785939,"marketCap":23120131584},{"date":"2026-05-15","current":-6.609967,"twenty":-18.384608,"median":-9.691452,"eighty":-8.751075,"marketCap":20699742808},{"date":"2026-05-22","current":-6.440114,"twenty":-18.185423,"median":-9.652725,"eighty":-8.708072,"marketCap":20121739519},{"date":"2026-05-29","current":-6.506712,"twenty":-18.096065,"median":-9.620334,"eighty":-8.669056,"marketCap":20400514838},{"date":"2026-06-05","current":-5.374082,"twenty":-18.0452,"median":-9.575685,"eighty":-8.511806,"marketCap":16873830092},{"date":"2026-06-12","current":-5.36331,"twenty":-17.183112,"median":-9.557279,"eighty":-8.481744,"marketCap":16828616185},{"date":"2026-06-18","current":-5.321722,"twenty":-16.860136,"median":-9.537613,"eighty":-8.412993,"marketCap":16738188371},{"date":"2026-06-26","current":-4.703556,"twenty":-16.761475,"median":-9.522579,"eighty":-8.375473,"marketCap":14721648119},{"date":"2026-07-03","current":-6.212828,"twenty":-16.718804,"median":-9.508222,"eighty":-8.310046,"marketCap":19460065572},{"date":"2026-07-10","current":-6.457487,"twenty":-16.608112,"median":-9.462457,"eighty":-8.218812,"marketCap":20201573647},{"date":"2026-07-17","current":-6.192643,"twenty":-16.533051,"median":-9.445101,"eighty":-8.097368,"marketCap":19441980010},{"date":"2026-07-24","current":-6.744145,"twenty":-16.505793,"median":-9.428231,"eighty":-7.995787,"marketCap":21178194038},{"date":"2026-07-31","current":-5.225281,"twenty":-16.472851,"median":-9.409879,"eighty":-7.856069,"marketCap":16439776585},{"date":"2026-08-07","current":-5.555188,"twenty":-16.434203,"median":-9.398864,"eighty":-7.73561,"marketCap":17511664790},{"date":"2026-08-14","current":-5.519506,"twenty":-16.417169,"median":-9.342917,"eighty":-7.473767,"marketCap":17421211976},{"date":"2026-08-21","current":-5.561665,"twenty":-16.354018,"median":-9.310353,"eighty":-6.918832,"marketCap":17593072323},{"date":"2026-08-28","current":-5.723357,"twenty":-16.253166,"median":-9.270261,"eighty":-6.767757,"marketCap":18108653362},{"date":"2026-09-04","current":-9.738306,"twenty":-16.191745,"median":-9.310353,"eighty":-6.781144,"marketCap":16344823489},{"date":"2026-09-09","current":-9.894924,"twenty":-16.166712,"median":-9.338798,"eighty":-6.786974,"marketCap":16634272494}],"updateTime":1789076666636},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09606\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1182504270","title":"DUALITYBIO-B (09606) Spends HK$6.5144 Million on Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1182504270","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182504270?lang=en_us&edition=fundamental","pubTime":"2026-05-26 22:16","pubTimestamp":1779804976,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) announced that on May 26, 2026, the company repurchased 30,000 shares, spending a total of HK$6.5144 million. The repurchase price per share ranged from HK$216.2 to HK$218.4.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000500386.USD","LU2543165471.USD","09606","HK0000252160.HKD","HK0000252152.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120438059","title":"LAV Asset Management Boosts Stake in DUALITYBIO-B with 105,000 Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1120438059","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120438059?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:38","pubTimestamp":1779795502,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on May 20, LAV Asset Management (Hong Kong) Limited increased its holding in DUALITYBIO-B (09606) by 105,000 shares. The transaction...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","09606","EWH","HK0000252152.HKD","LU2543165471.USD","BK1161","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636894779","title":"Duality Biotherapeutics Launches $40 Million Stock Buyback; Shares Rise 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636894779","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636894779?lang=en_us&edition=fundamental","pubTime":"2026-05-20 11:12","pubTimestamp":1779246731,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics  announced plans to buy back up to $40 million worth of its shares from the open market, according to a Tuesday filing with the Hong Kong bourse.The biopharmaceutical firm's shares gained over 3% in morning trade on Wednesday.The company said its current share price does not reflect its intrinsic value, representing a good opportunity to conduct the buyback.Meanwhile, Duality Bio Chairman and Chief Executive Officer Zhu Zhongyuan plans to increase his shareholding in the company by spending up to $5 million to buy shares in the secondary market.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HK0000252152.HKD","LU2543165471.USD","HK0000500386.USD","BK1161","HK0000252160.HKD","09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117028827","title":"DualityBio-B Surges Nearly 5% in Morning Trading, Announces Up to $40 Million Share Buyback Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1117028827","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117028827?lang=en_us&edition=fundamental","pubTime":"2026-05-20 10:00","pubTimestamp":1779242437,"startTime":"0","endTime":"0","summary":"DualityBio-B (09606) saw its stock price rise over 6% during the trading session. At the time of reporting, the stock was up 4.83%, trading at HKD 225.80 with a turnover of HKD 97.17 million. On May...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","09606","HK0000252160.HKD","BK1161","HK0000500386.USD","LU2543165471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152410415","title":"Movement Alert｜Duality Biotherapeutics Rises 5.66% in Regular Trading, Share Buyback Plan Triggers Rebound After Multi-Day Selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=1152410415","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152410415?lang=en_us&edition=fundamental","pubTime":"2026-05-20 09:32","pubTimestamp":1779240740,"startTime":"0","endTime":"0","summary":"On May 20, Duality Biotherapeutics rose 5.66% in regular trading, trading at 217.2 HKD/share, with trading volume of 23.78 million HKD. The stock rebounded after falling from approximately 257 HKD to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112436808","title":"DUALITYBIO-B (09606) Announces Up to $40 Million Share Buyback, Founder Plans Additional $5 Million Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1112436808","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112436808?lang=en_us&edition=fundamental","pubTime":"2026-05-19 22:17","pubTimestamp":1779200266,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) announced that its Board of Directors intends to utilize the general mandate granted by shareholders at the Annual General Meeting held on June 20, 2025, to repurchase the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","BK1161","HK0000252160.HKD","09606","HK0000500386.USD","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636852359","title":"Duality Biotherapeutics Inc - Announces Share Repurchase Plan of up to $40 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2636852359","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636852359?lang=en_us&edition=fundamental","pubTime":"2026-05-19 22:08","pubTimestamp":1779199739,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nFWN41W0AC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2543165471.USD","HK0000252160.HKD","BK1161","HK0000252152.HKD","09606","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139994451","title":"DUALITYBIO-B Exercises Option for U.S. Cost and Profit/Loss Sharing on DB-1311/BNT324","url":"https://stock-news.laohu8.com/highlight/detail?id=1139994451","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139994451?lang=en_us&edition=fundamental","pubTime":"2026-05-13 06:38","pubTimestamp":1778625504,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) announced that on May 12, 2026, Hong Kong Time (the \"Exercise Date\"), the company provided written notice to BioNTech SE (\"BioNTech\"), whose shares are listed on the Nasdaq Stock...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","LU2543165471.USD","BK4566","BK4118","HK0000252152.HKD","BK4585","BK4588","BK4552","BK1161","HK0000500386.USD","09606","DB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104659656","title":"Duality Biotherapeutics Exercises U.S. Cost- and Profit-Sharing Option for ADC Candidate DB-1311/BNT324 in Collaboration with BioNTech","url":"https://stock-news.laohu8.com/highlight/detail?id=1104659656","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104659656?lang=en_us&edition=fundamental","pubTime":"2026-05-13 06:22","pubTimestamp":1778624576,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics, Inc. (Duality Biotherapeutics) has formally exercised its exclusive cost and profit/loss sharing option for the antibody-drug conjugate (ADC) DB-1311/BNT324 in the United...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166588783","title":"HK Movers | Biotech Stocks Jump. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166588783","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166588783?lang=en_us&edition=fundamental","pubTime":"2026-05-11 13:30","pubTimestamp":1778477425,"startTime":"0","endTime":"0","summary":"Biotech stocks jumped in Hong Kong. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359","03759","02269","06606","06978","09688","09995","02137","01672","09606","09966","03347","02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103858173","title":"DualityBio-B Adds 0.19 Million New Shares in April; Public Float Remains Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1103858173","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103858173?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:03","pubTimestamp":1778151794,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics, Inc. (DualityBio-B) filed its monthly return for the period ended 30 April 2026, highlighting incremental equity issuance driven by option exercises while maintaining...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631513242","title":"Duality Biotherapeutics shareholders approved RMB share issue plan at EGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2631513242","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631513242?lang=en_us&edition=fundamental","pubTime":"2026-04-29 19:32","pubTimestamp":1777462356,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics held an extraordinary general meeting on April 29, 2026, passing all resolutions put to shareholders.Shareholders authorized a proposed RMB Share Issue, granting a specific mandate for the issuance.Board received authority to handle matters relating to RMB Share Issue, including related implementation steps.Shareholders endorsed plans tied to RMB Share Issue, including a three-year RMB share price stabilization plan, a three-year dividend return plan, a plan to address accumulated unrecovered losses, use of proceeds, and measures to mitigate dilution of immediate returns.Meeting adopted new procedural rules for shareholder general meetings and board meetings, approving amendments to articles of association, with effectiveness tied to date of listing of RMB Shares on Sci-Tech Board.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL35HBcs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU2543165471.USD","HK0000500386.USD","HK0000252160.HKD","09606","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124616358","title":"HK Movers | Biotech Stocks Jump. Wuxi Apptec Soars 14% as 1Q Net Profit Rises 26.7%; Junshi Bio up 8%; Asymchem up Nearly 7%; Pharmaron up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1124616358","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124616358?lang=en_us&edition=fundamental","pubTime":"2026-04-28 10:06","pubTimestamp":1777342004,"startTime":"0","endTime":"0","summary":"Biotech stocks jumped in Hong Kong market. Wuxi Apptec soared 14% as 1Q net profit rose 26.7%; Junshi Bio up 8%; Asymchem up nearly 7%; Wuxi XDC up 5%; Pharmaron up 4%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06606","02269","02359","03759","09688","09995","02268","03347","06978","09966","02137","09606","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164489207","title":"DUALITYBIO-B 2025年度：营收约18.52亿元小幅下滑，净亏损增至25.95亿元，股本由负转正","url":"https://stock-news.laohu8.com/highlight/detail?id=1164489207","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164489207?lang=en_us&edition=fundamental","pubTime":"2026-04-26 19:26","pubTimestamp":1777202773,"startTime":"0","endTime":"0","summary":"根据公告资料，Duality Biotherapeutics（简称“DUALITYBIO-B”）于2025年实现全年收入约18.52亿元，同比下降4.6%。公司聚焦新一代抗体偶联药物（ADC）研发，两款核心产品DB-1303/BNT323（HER2 ADC）及DB-1311/BNT324（B7-H3...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"DUALITYBIO-B 2025年度：营收约18.52亿元小幅下滑，净亏损增至25.95亿元，股本由负转正","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630889387","title":"DualityBio publishes 2025 ESG report","url":"https://stock-news.laohu8.com/highlight/detail?id=2630889387","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630889387?lang=en_us&edition=fundamental","pubTime":"2026-04-26 19:24","pubTimestamp":1777202666,"startTime":"0","endTime":"0","summary":"DualityBio released its 2025 environmental, social, and governance report, highlighting 2025 revenue of about RMB 1.85 billion.Report flagged commercialization progress, with one product expected to be launched.Pipeline update showed 13 proprietary ADC candidates, including 10 clinical-stage assets.Global development footprint included 10 clinical trials across more than 230 centers in 17 countries, with over 3,200 patients enrolled.Climate disclosure expanded to first-time Scope 3 carbon accounting in 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Duality Biotherapeutics Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on Apri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260426:nNDL7HtJsN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000500386.USD","BK1161","HK0000252160.HKD","HK0000252152.HKD","LU2543165471.USD","09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165196464","title":"HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165196464","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165196464?lang=en_us&edition=fundamental","pubTime":"2026-04-23 11:32","pubTimestamp":1776915127,"startTime":"0","endTime":"0","summary":"HK biotech stocks fell. Akeso down 12%; Remegen, Zai Lab, KeyMed and Junshi down 7%; Lepu and Innocare down 6%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268","02162","06606","09606","09995","06978","02269","02137","02359","09926","03347","01672","09966","09688","03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124678664","title":"China International Capital Corporation: National Policy Optimizes Initial Pricing Mechanism for Innovative Drugs, Pharmaceutical Sector Set for High-Quality Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1124678664","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124678664?lang=en_us&edition=fundamental","pubTime":"2026-04-16 14:39","pubTimestamp":1776321543,"startTime":"0","endTime":"0","summary":"China International Capital Corporation (CICC) has released a research report stating that on April 14th, the General Office of the State Council issued the \"Several Opinions on Improving the Drug...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1191","LU1251922891.USD","BK1574","LU0417516738.SGD","LU1719994722.HKD","LU2242644610.SGD","LU1969619763.USD","IE00B543WZ88.USD","01276","IE00B5MMRT66.SGD","LU0588546209.SGD","BK1161","LU2097828474.EUR","LU0348766576.USD","06160","06978","HK0000500386.USD","HK0000165453.HKD","LU0348825331.USD","LU0359201612.USD","LU1770034418.SGD","LU2399975544.HKD","LU2778985437.USD","LU2328871848.SGD","BK1583","LU1023057109.AUD","LU2097828805.USD","LU2097828557.USD","LU1961090484.USD","LU1720050803.USD","LU0348783233.USD","LU2543165471.USD","LU0307460666.USD","BK1589","IPOS","LU0348735423.USD","LU0417516902.SGD","LU0502904849.HKD","01801","LU0634319403.HKD","LU2476274720.SGD","159992","LU0359202008.SGD","LU2488822045.USD","LU1794554557.SGD","LU0540923850.HKD","LU2476274308.USD","LU2097828714.EUR","LU0348827113.USD","BK1500","LU0359201885.HKD","HK0000252152.HKD","LU0417516571.SGD","BK1588","09926","HK0000252160.HKD","IE00BPRC5H50.USD","LU0348784397.USD","LU0561508036.HKD","LU0348767384.USD","09606","LU0455707207.USD","LU2097828631.EUR","LU1303224171.USD","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170833307","title":"Stock Track | DUALITYBIO-B Soars 5.02% Intraday on STAR Market Listing Plan Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1170833307","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170833307?lang=en_us&edition=fundamental","pubTime":"2026-04-15 09:33","pubTimestamp":1776216839,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B's stock price surged 5.02% during intraday trading on Wednesday, following the company's announcement of plans to pursue a secondary listing on China's STAR Market. The biopharmaceutical...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172774249","title":"DualityBio-B Advances Global ADC Leadership with Dual Capital Platform Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1172774249","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172774249?lang=en_us&edition=fundamental","pubTime":"2026-04-15 08:03","pubTimestamp":1776211396,"startTime":"0","endTime":"0","summary":"On the evening of April 13, leading ADC company DualityBio-B (09606) announced that its board of directors has approved a plan to issue RMB-denominated shares and list on the STAR Market. The company...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","LU2543165471.USD","09606","HK0000252152.HKD","HK0000500386.USD","BK4231","HK0000252160.HKD","ADC","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154397574","title":"DualityBio Convenes 29 April 2026 EGM to Approve RMB Share Issue and Corporate Governance Amendments","url":"https://stock-news.laohu8.com/highlight/detail?id=1154397574","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154397574?lang=en_us&edition=fundamental","pubTime":"2026-04-14 21:21","pubTimestamp":1776172912,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics, Inc. (DualityBio) has issued a proxy form ahead of an Extraordinary General Meeting (EGM) scheduled for 9:00 a.m. on 29 April 2026 at its Shanghai headquarters, Board Room,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":6,"totalSize":156,"code":"91000000","status":"200"}]}}